Beijing’s government announced on Wednesday plans to enforce a Chinese coronavirus vaccine mandate on select members of its population of roughly 21.3 million starting next week, China’s state-run Global Times reported.
” To further implement normalized epidemi prevention and control and consolidate achievements, protect the safety and health of the public especially the elderly, Beijing intends to roll out an array of epidemic prevention-control measures,” reported the newspaper on July 6.
“The new regulations stipulate that from July 11, 2022, Beijing residents should be vaccinated (with exceptions for those not suited to vaccination) before entering public venues, including in-person training institutions, libraries, museums, cinemas, art galleries, culture centers, sports venues, gyms, performance and entertainment settings and internet cafes,” the Global Times relayed.
” “Also, seniors who are permitted to enter college or other venues that offer entertainment must be vaccinated,” said the Chinese Communist Party-controlled newspaper.
Party claim that Beijing is currently fighting an epidemic of Chinese coronavirus. This year’s nationwide outbreak of coronavirus in China is part of an epidemic that has affected the Chinese capital. China’s Communist Party has taken snap measures to protect some large communities.
The policy forced Shanghai’s government to confine all of its 25 million-plus residents to their homes for 65 consecutive days after new Chinese coronavirus infections emerged in the city in mid-March. While Shanghai’s municipal government claimed that the city’s stay-at-home order lasted from March 28 to June 1, movement restrictions remained in place across the financial hub throughout June, crippling its normally lucrative economy. Shanghai announced a new, snap lockdown across 12 of the city’s 16 residential districts on July 5, so that municipal health workers could conduct mass testing for the Chinese coronavirus amid a fresh outbreak of the disease.
The Global Times July 6 didn’t specify which type of Chinese coronavirus vaccinations Beijing required residents to get as part its impending vaccine mandate.
A nurse holds a vial of the CoronaVac vaccine -developed by China’s Sinovac laboratory- against the COVID-19 disease, in Bogota on March 9, 2021. (Photo by JUAN BARRETO/AFP via Getty Images)
China’s health ministry has approved six different types of domestically developed Chinese coronavirus vaccines and vaccine candidates for use in the country. The following Chinese and Chinese state-owned biotech and pharmaceutical companies have offered six types of domestically developed Chinese coronavirus vaccines and candidates for use in China: Anhui Zhifei Loongcom (“Zifivax”, based upon protein subunit technology; CanSino (“Convidecia,” based off non-replicating virus vector technology); Shenzhen Kangtai Biological Products Co. (“KCONVAC,” based inactivated vaccination technology); Sinopharm Wuhan (“Inactivated Cells,” based vaccine technology); and Sinovac (“CoronaVac” based inactivated technology); and Sinovac (“CoronaVac”)
The World Health Organization (W.H.O. explains inactivated vaccine technology on its website, writing:
The first way to make a vaccine is to take the disease-carrying virus or bacterium, or one very similar to it, and inactivate or kill it using chemicals, heat or radiation. This method uses proven technology – it’s how the flu and polio vaccines were made. It can also be done on a small scale.
However, to safely grow the virus/bacterium, you will need special laboratory equipment and may require several doses.
A protein subunit vaccine, according to W.H.O. “only uses very specific parts (subunits of viruses or bacteria that the immune system must recognize,” It doesn’t include the entire microbe, nor does it use safe viruses as a vector. Subunits can be either proteins or sugars. Most of the vaccines on the childhood schedule are subunit vaccines, protecting people from diseases such as whooping cough, tetanus, diphtheria and meningococcal meningitis.”
The U.N.’s international public health agency describes viral vector vaccine technology in this way: “A safe virus is used to deliver sub-parts of the germ that are called proteins so it can trigger an immune reaction without causing any disease .”
” To do this, instructions are added to a virus that is safe. This safe virus acts as an intermediary or vector for the delivery of the protein to the body. This protein activates an immune response. According to the W.H.O., Ebola is a virus vector vaccine that can be quickly developed.”
The W.H.O. criticized China’s “zero tolerance” policy toward the Chinese coronavirus and its associated lockdowns as “unsustainable” on May 10.